Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech
en
Read more

Getting Ready for the Recovery in Healthcare M&A

Companies willing to invest shrewdly in the downturn will emerge from it stronger.
Explore the full report

Coming Soon: M&A Report 2026

Inside the resurgence of M&A in 2025 and what it means for the year ahead.
First published in mars 2021
Mots clés

Comment nous avons aidé nos clients

A Pharma Company’s Finance Function Gets a Shot in the Arm

Lire l’étude de cas

Pharma oncology growth strategy

Lire l’étude de cas

Recharging the pharmaceutical sales model

Lire l’étude de cas

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.

Contacter Bain

Comment pouvons-nous vous aider ?

Voir tous les bureaux